Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | -42.70% | 21.29% | 62.44% | 47.63% | 56.18% |
| Total Depreciation and Amortization | -50.00% | -37.33% | -45.98% | -46.59% | 138.25% |
| Total Amortization of Deferred Charges | 904.76% | -64.29% | -97.50% | -98.63% | 102.08% |
| Total Other Non-Cash Items | 217.59% | -68.79% | -94.35% | -84.82% | -117.75% |
| Change in Net Operating Assets | -135.59% | 82.54% | 121.59% | -53.63% | 67.30% |
| Cash from Operations | -640.74% | 55.85% | 68.48% | -803.55% | 78.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | -160.00% | 43.75% | 96.00% |
| Cash from Investing | 100.00% | 100.00% | 64.86% | 43.75% | 96.00% |
| Total Debt Issued | 918.80% | -- | -- | 90.00% | -43.50% |
| Total Debt Repaid | -57.53% | -44.32% | 84.42% | 74.96% | 19.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,103.75% | 84.39% | -63.36% | 8.30% | -85.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 530.23% | 88.84% | 513.79% | -130.24% | -223.74% |
